Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 10 min ago
Peer-reviewedCC BY-NCBMJ open ophthalmology

Non-inferiority study of the efficacy of ranibizumab BS compared with aflibercept in patients with macular oedema due to untreated branch retinal vein occlusion: REMEDY-BRVO study - study protocol.

  • Ai Toride1
  • Kenta Ashikaga2
  • Shutaro Yamamoto2
  • Takanori Nakagawa3
  • Ayumi Ouchi-Usui4
  • Atsuhide Takesue5
  • Gaku Ishida6
  • Yoshinari Sadamatsu7
  • Kazutaka Adachi8
  • Toshihiko Ohta9
  • Koichi Ono10
  • Daisuke Takami11
4 more authors
  • Tetsuya Tajika12
  • Toshiaki Hirakata5
  • Yoshimune Hiratsuka3
  • Shintaro Nakao13
13 affiliations
  1. 1Juntendo University, Bunkyo, Tokyo, Japan.
  2. 2Department of Ophthalmology, Juntendo Daigaku - Hongo Campus, Bunkyo, Tokyo, Japan.
  3. 3Department of Ophthalmology, Juntendo University - Hongo Campus, Bunkyo, Tokyo, Japan.
  4. 4Ophthalmology, Juntendo University Urayasu Hospital, Urayasu, Japan.
  5. 5Department of Ophthalmology, Juntendo University Nerima Hospital, Nerima, Tokyo, Japan.
  6. 6Ophthalmology, Ishida Eye Clinic, Joetsu, Niigata Prefecture, Japan.
  7. 7Ophthalmology, Sadamatsu Eye Clinic, Kasukabe, Saitama, Japan.
  8. 8Ophthalmology, Adachi Eye Clinic, Kazo, Saitama, Japan.
  9. 9Department of Ophthalmology, Juntendo University Shizuoka Hospital, Izunokuni, Shizuoka Prefecture, Japan.
  10. 10Ophthalmology, Juntendo Tokyo Koto Geriatric Medical Center, Koto-ku, Tokyo, Japan.
  11. 11Senju Pharmaceutical Co Ltd Kobe Creative Center, Kobe, Hyogo Prefecture, Japan.
  12. 12Senju Pharmaceutical Co Ltd Kobe Innovative Center, Kobe, Hyogo Prefecture, Japan.
  13. 13Department of Ophthalmology, Juntendo University - Hongo Campus, Bunkyo, Tokyo, Japan [email protected].
Read full textPDFDOICite

Related

  1. Effects of recurrent aflibercept and ranibizumab on intraocular pressure in diabetic retinopathy and age-related macular degeneration
    Güvenç Toprak, Serdal Çelebi, Fatih Ulaş
    Therapeutic Advances in OphthalmologyPeer-reviewedCC BYFull textGeneral medicineDOAJ
  2. A Distinct Delayed-Onset Intraocular Inflammation Phenotype of Faricimab versus Aflibercept and Ranibizumab: Triangulated Pharmacovigilance Evidence from Databases of US, Europe and Japan
    J. Jiang, Y. Gu, D. Hu +6
    medRxivPreprintCC BY-NCFull textPharmacology & toxicologymedRxiv
  3. PROSPECTIVE COMPARISON OF OPTIMIZED COMPRESSED SENSING AND GRAPPA-ACCELERATED 3D-TOF-MRA FOR EVALUATION OF UNTREATED INTRACRANIAL ANEURYSMS AT 1.5 T: A NON-INFERIORITY STUDY
    C. G. Iacoban, H. Bösenberg, C. Klüner +5
    medRxivPreprintCC BY-NC-NDFull textMedical imaging & radiologymedRxiv
  4. Faricimab 6 mg versus aflibercept 8 mg in diabetic macular oedema: an in silico study of anchored efficacy and common-protocol treatment burden
    Georgios D. Panos
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Full textPharmacology & toxicologyCrossrefEurope PMCPMC
  5. Improved efficacy of orelabrutinib plus rituximab, temozolomide and high-dose methotrexate versus rituximab, high-dose methotrexate plus temozolomide in untreated primary CNS lymphoma: A matched analysis
    Peng Zhang, Man Nie, Hang Yang +8
    Neuro-Oncology AdvancesPeer-reviewedCC BY-NC 4.0Full textNeurologyPMC

Cite

BibTeXRIS
BibTeX
@article{toride2026noninferiority,
  title = {{Non-inferiority study of the efficacy of ranibizumab BS compared with aflibercept in patients with macular oedema due to untreated branch retinal vein occlusion: REMEDY-BRVO study - study protocol.}},
  author = {Ai Toride and Kenta Ashikaga and Shutaro Yamamoto and Takanori Nakagawa and Ayumi Ouchi-Usui and Atsuhide Takesue and Gaku Ishida and Yoshinari Sadamatsu and Kazutaka Adachi and Toshihiko Ohta and Koichi Ono and Daisuke Takami and Tetsuya Tajika and Toshiaki Hirakata and Yoshimune Hiratsuka and Shintaro Nakao},
  journal = {BMJ open ophthalmology},
  year = {2026},
  month = oct,
  doi = {10.1136/bmjophth-2026-002799},
  url = {https://europepmc.org/article/MED/42880818},
  note = {CC BY-NC},
}
RIS
TY  - JOUR
TI  - Non-inferiority study of the efficacy of ranibizumab BS compared with aflibercept in patients with macular oedema due to untreated branch retinal vein occlusion: REMEDY-BRVO study - study protocol.
AU  - Ai Toride
AU  - Kenta Ashikaga
AU  - Shutaro Yamamoto
AU  - Takanori Nakagawa
AU  - Ayumi Ouchi-Usui
AU  - Atsuhide Takesue
AU  - Gaku Ishida
AU  - Yoshinari Sadamatsu
AU  - Kazutaka Adachi
AU  - Toshihiko Ohta
AU  - Koichi Ono
AU  - Daisuke Takami
AU  - Tetsuya Tajika
AU  - Toshiaki Hirakata
AU  - Yoshimune Hiratsuka
AU  - Shintaro Nakao
PY  - 2026
DA  - 2026/10/15
JO  - BMJ open ophthalmology
DO  - 10.1136/bmjophth-2026-002799
UR  - https://europepmc.org/article/MED/42880818
SN  - 2397-3269
ER  -